Time series-based transcriptome analysis. All iPSC lines used in this study were obtained from a cohort of eight idiopathic ASD Autism spectrum disorder (ASD) is thought to emerge during early cortical development. However, the exact developmental stages and associated molecular networks that prime disease propensity are elusive. To profile early neurodevelopmental alterations in ASD with macrocephaly, we monitored subject-derived induced pluripotent stem cells (iPSCs) throughout the recapitulation of cortical development. Our analysis revealed ASD-associated changes in the maturational sequence of early neuron development, involving temporal dysregulation of specific gene networks and morphological growth acceleration. The observed changes tracked back to a pathologically primed stage in neural stem cells (NSCs), reflected by altered chromatin accessibility. Concerted over-representation of network factors in control NSCs was sufficient to trigger ASD-like features, and circumventing the NSC stage by direct conversion of ASD iPSCs into induced neurons abolished ASD-associated phenotypes. Our findings identify heterochronic dynamics of a gene network that, while established earlier in development, contributes to subsequent neurodevelopmental aberrations in ASD.
A utism spectrum disorder is a highly heritable neurodevelopmental condition defined by deficits in social interaction and communication accompanied by restrictive, repetitive behaviors. Considerable genetic and phenotypic heterogeneity has complicated the efforts to find common biological substrates of the syndrome. Meanwhile, recent advances in systems biology approaches have caused a paradigm shift in the field of biomedical sciences from a single-gene causation model to pathway perturbation models 1, 2 . Implementing high-confidence risk variants discovered in ASD cohorts into a data-driven framework of gene network analysis revealed a convergence on molecular processes that implicate specific perturbations during human fetal cortical development 3, 4 . One complication is that many of the genes identified are involved at multiple time points and in different neural cell types, such as neural stem cells (NSCs), as well as in maturing neurons during human cortical development. Thus, a major challenge in the field is to determine the critical developmental periods, their associated cellular states and the molecular networks that might provide a basis for the emergence of common pathological phenotypes during ASD development.
Here we have performed a time series analysis to follow human idiopathic ASD subject-specific iPSCs during their early neuronal development to examine when and how the earliest ASD-specific molecular abnormalities and phenotypes arise. Time series transcriptome and cellular phenotype analyses in ASD NSCs and their progeny identified dysregulation of specific transcriptional networks that caused aberrant neuronal maturation of ASD cortical neurons. Temporal reconstruction and network-based screening revealed that coherent neurodevelopmental gene modules were accelerated in ASD and appeared to be enriched with several ASD risk genes. Surprisingly, we found that dysregulation of these modules arose even before the neuronal stage, as module-specific signatures were already present during the NSC stage. Genome-wide comparisons of chromatin accessibility revealed a prevalent pathologically primed state in ASD NSCs that precedes the occurrence of aberrant gene network dynamics at the consecutive neuronal stage. Concerted transgenic expression of subsets of module genes was used to mimic ASD-associated gene network-related changes in healthy controls, and was sufficient to recapitulate the occurrence of aberrant neurodevelopmental growth trajectories at the subsequent neuronal stage. We further demonstrated that skipping the NSC stage by direct iPSC-to-neuron conversion (iPSC-iN) also circumvented the critical period for the ASD signature to establish itself, thereby preventing neuronal ASD phenotypes from manifesting. Our study provides a thorough temporal analysis of the neurodevelopmental regulatory gene networks that become impaired in ASD, and shows that some of these changes are triggered during early developmental periods.
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NATure NeurOSCieNCe subjects with early developmental brain overgrowth, and five unaffected individuals as controls. Children with such signs of early brain enlargement have been shown to be part of a group of subjects with a high probability of receiving diagnosis [5] [6] [7] [8] . Primary skin fibroblasts were harvested and reprogrammed to iPSCs using retroviral vectors expressing the four Yamanaka factors 9 ( Supplementary Fig. 1a and Supplementary Table 1 ). Our previous study showed that neuronal cultures derived from these subjects bear an impaired neuronal network connectivity at later, more mature, neuronal stages. Other iPSC studies have also reported aberrant features of neuronal connectivity as a phenotypic hallmark for various forms of autism [9] [10] [11] . However, whether dynamic neurodevelopmental aberrations exist that precede the appearance of such advanced phenotypic disease states remains unresolved. Integrative bioinformatics approaches suggest that ASD pathologies may arise from combined deficiencies during distinct phases of human cortical development 3, 4 . To model these early periods, we differentiated the iPSCs into NSCs and then further into functional excitatory MAP2 + neurons ( Supplementary  Fig. 1b-d ) using a reported protocol 9, 12 . All subject-derived cells adopted a cortical fate (Supplementary Figs. 1e-h and 2a,b), and global transcriptional comparison to the BrainSpan dataset 13 revealed high correspondence to the dorsal telencephalon (cerebral cortex with dorsolateral, medial and orbitofrontal cortical areas) during early human fetal cortical development ( Supplementary  Fig. 2c-e ). Furthermore, continuous electrophysiological recordings showed a consecutive transition through stages of functional maturation, including the firing of multiple evoked action potentials after 22 days of differentiation ( Supplementary Fig. 2f ).
One major aim of this study was to model the temporal dimension of shifting biological processes by treating the disorder as an evolving, dynamic system. We reasoned that a tight recapitulation of the consecutive developmental stages of early neuronal development in ASD and control cases would allow us to reconstruct time-related maturational processes. We first used fluorescence-activated cell sorting (FACS) to purify a homogeneous population of NSCs based on the expression of the cell-surface markers CD184 + /CD271 − / CD44 − /CD24 − /CD15 + (ref. 14 ) . To trace ASD and control neurons over time, we performed a series of retroviral lineage-tracing experiments to isolate the progenies of dividing NSCs using a retroviral vector expressing a membrane-tagged enhanced green fluorescent protein (eGFP) (CAG::LckN-eGFP). Because differentiating neurons express PSA-NCAM on the cell surface ( Supplementary  Fig. 3a,b ), we established a FACS-based protocol for purification of defined subpopulations of retrovirally labeled eGFP + /PSA-NCAM + double-positive neurons after 2, 4, 7 and 14 days of differentiation ( Fig. 1a) , which allowed us to capture several consecutive maturational stages during lineage progression. We next performed RNA sequencing (RNA-seq) analysis over the time course of neuronal differentiation and observed dramatic but gradual changes in gene expression ( Supplementary Fig. 3c ). As expected, neuronal genes such as MAP2, MAPT and DCX, voltage-gated channels, synaptic proteins and neurotransmitter receptors (such as GRIN3a and GRIA3) became gradually upregulated, whereas cell cycle-associated genes were consecutively downregulated ( Supplementary Fig. 3c , left panel and Supplementary Table 2 ). Gene ontology term analysis of differentially upregulated genes revealed highly significant enrichment for biological processes that control neuron generation and function ( Supplementary Fig. 3c , right panel). A highly significant enrichment for factors that control cell cycle and proliferation was present in the list of the most strongly decreased genes ( Supplementary Fig. 3c , right panel and Supplementary Table 3 ), indicating efficient purification of maturing neurons from defined time points during neuronal differentiation.
Identification of aberrant gene network dynamics in ASD.
We next sought to decipher the dynamics of regulatory gene networks to identify deviations in time-critical aspects during ASD development. To cluster genes with similar expression patterns in an unbiased manner, we applied weighted gene co-expression network analysis (WGCNA) 15, 16 to all 65 time series samples (five control and eight ASD lines at five time points) and identified 44 modules of co-expressed genes ( Fig. 1b , Supplementary Table 4 and Methods). Here, modules with high gene numbers mostly corresponded to changes within developmental time ( Fig. 1b) , whereas cell stage-specific events appeared to be a more subtle transcriptional feature reflected in a number of smaller modules ( Fig. 1c and Supplementary Fig. 4a ). As developmental progression is based on a sequence of events that change over time, we were particularly interested in those modules that showed enrichment for genes holding dynamic temporal profiles. Defining a time-based module significance measure (Methods) allowed us to identify three modules that showed a highly significant correlation with the progression of neurodevelopmental timing, referred to as time modules (TMs) 1, 2 and 3 ( Fig. 1d ). Alternative network construction strategies (Supplementary Methods) further demonstrated the robustness in identifying all three TMs, suggesting a high preservation within our gene network ( Supplementary Fig. 4d and e).
To identify temporal deviations within the developmental sequence between ASD and control neurons, we compared temporal gene expression dynamics on the level of the identified gene modules. To overcome the lack of sensitivity to distortion in the time axis when using the Euclidean distance metric, we applied dynamic time-warping (DTW) algorithms to compare temporal module dynamics between ASD and control neurons. DTW is a variety of time series alignment algorithms designed to measure similarities between two temporal sequences that may vary in speed 17, 18 . Module eigengenes (first principal component of a given module) were used as a representative of the gene expression profiles in the three TMs ( Fig. 2a ). DTW was then applied to compare the module-based dynamics between ASD and control neurons, revealing distinct deviations between the two time series in TM1 ( Fig. 2b, left) . The two other TMs showed only subtle initial timeline deviations (Fig. 2b , middle and right panels, Supplementary  Fig. 4b ,c), indicating that the temporal sequences in TM2 and TM3 were almost similar between ASD and control neurons. The temporal progression of TM1, however, appeared markedly accelerated in ASD neurons, with earlier time points corresponding to later time points in control neurons ( Fig. 2c ), highlighting the emergence of an intrinsic molecular heterochronicity.
To further evaluate the identified developmental gene networks, we computed the relative enrichment for disease-related risk factors in each module based on a set of 859 genes ( Supplementary  Table 5 ) evaluated by the Simons Foundation Autism Research Initiative knowledge base 19 . Remarkably, TM1 and TM2 showed specific enrichment for ASD risk genes with both featuring highly significant enrichment scores as compared to other modules ( Fig. 2d ). As further evidence for this confined enrichment, gene expression changes identified in postmortem ASD cortex studies 20, 21 and during human cortical development 3 , as well as genes with de novo variants associated with intellectual disability 22 , showed significant enrichment in both TMs ( Supplementary Fig. 4f ). This confined enrichment in TMs suggests an involvement of autism risk factors in the early phases of cortical neuron development, consistent with other recent studies 3, 4 , and relates our findings to relevant ASD-associated changes that are present at later stages.
Characterization of the accelerated ASD TM1. Gene ontology term analysis of the genes assigned with TM1 revealed highly significant enrichment for biological processes that control specific aspects of nervous system development (P = 2.8 × 10 −28 ), including neuron differentiation (P = 2.7 × 10 −18 ), the development of neuronal projections (P = 3.4 × 10 −15 ), cell morphogenesis (P = 3.1 × 10 −15 ) Articles NATure NeurOSCieNCe and synaptic signaling (P = 2.6 × 10 −20 ) ( Fig. 3a , Supplementary  Table 6 ). As TM1 increases expression with time, the large neurodevelopmental signature of this module suggests that these genes reflect gradually increasing neuronal differentiation. Highly connected genes ('hub genes') such as BRSK1, CACNB1, RAB3A and GPC2, together with several other interconnected hub genes, are involved in neuron generation and synapse organization ( Fig. 3b ). To further characterize TM1, we calculated individual gene significance measures for the top 60 hub genes by correlating their expression with developmental time and condition. As expression of these genes increases with developmental time, these measures reach highly positive values at later, more mature, neuronal stages ( Fig. 3c ). When comparing the hub gene trajectories of ASD and control neurons, a pronounced shift in gene significance values markedly emerged at 4 days after differentiation and continued to be prominent at later time points, although differences were already present at the NSC stage ( Fig. 3c ), suggesting an ASD-specific priming of gene expression already present in pre-neuronal cells. Thus, given the large neurodevelopmental signature of TM1, the presence of such a marked time shift suggests aberrant neurodevelopmental gene network dynamics that could directly disturb the maturational sequence in developing ASD neurons.
Maturing ASD neurons show aberrant neurodevelopmental growth dynamics. We next explored the extent to which certain morphological aspects of ASD neuron development deviate from the 'normal' trajectory, in addition to the marked time shift observed at the transcriptional level. Therefore, a series of structural and morphometric analyses was performed on defined subpopulations of eGFP + /DCX + /PSA-NCAM + neurons using a retrovirusbased lineage-tracing approach (Fig. 4a,b and Supplementary  Fig. 5a ). Strikingly, and consistent with the shift observed in TM1, systematic reconstruction of individual morphological growth trajectories revealed a significant developmental acceleration in differentiating neurons from ASD subjects as compared to control neurons (Fig. 4c,d and Supplementary Fig. 5b ). In line with this finding, ASD neurons consistently featured branching patterns that were significantly more complex than those of control neurons ( Fig. 4e and Supplementary Fig. 5c ). Thus, given the marked time shift in TM1, these data highlight the presence of aberrant maturational dynamics, pertaining to the growth patterns of neuronal projections in developing ASD neurons. As the development of neuronal projections is a time-critical process, we further asked whether this growth acceleration might be accompanied by differences in the states of neuronal maturity. To query intrinsic maturational properties, we designed a retroviral tracing system expressing eGFP under the control of the human doublecortin promoter (hDcx::eGFP; Fig. 4f and Supplementary Fig. 5d ). Flow cytometry-based reporter analysis revealed a premature activity state of the introduced hDcx promoter in differentiating neurons from ASD subjects when compared to the trajectory of control neurons (Fig. 4g,h and Supplementary Fig. 5e ), indicating differences in both the initiation and dynamics of the neuronal program. Additional measures of maturational features revealed significant deviations in Supplementary Table 5 ).
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NATure NeurOSCieNCe the temporal progression of important developmental pathways ( Supplementary Fig. 6a-d ).
To further explore the developmental implications of this intrinsic neurodevelopmental heterochronicity, we used two different protocols to generate a three-dimensional (3D) model of cortical development 23, 24 . As monolayer cultures prove limited in revealing spatial effects on early cortical development, we used a subset of our cohort ( Supplementary Table 7 ) to assess the formation of the cortical plate in situ. While no major shift in specification of TBR1 + neurons was present in the monolayer system, cerebral organoids as well as TBR1 + cortical regions of forebrain organoids revealed an increased thickness of the cortical plate in the ASD condition ( Supplementary Fig. 6f -j), consistent with the hypothesis of increased neuronal numbers and proliferation 6, 9 . These results further emphasize the advantage of 3D models to dissect spatial developmental aberrations.
To exclude the possibility of cell heterogeneity and to study the aberrant cell-intrinsic trajectories, we labeled dividing radial glialike cells (RGLs) in the ventricular-like zones of 4-week-old forebrain organoids using a GFP-expressing retrovirus (Fig. 5a ). This approach allowed us to follow the progenies of labeled RGLs (Fig. 5b , top panels) as they migrated and integrated into the evolving cortical plate (Fig. 5b , bottom panels). In line with our findings from the NSC monolayer system, assessment of developing neurons revealed no difference in overall cell-fate commitment, as both ASD and control RGLs gave rise mostly to TBR1 + deep-layer neurons ( Fig. 5c and Supplementary Fig. 6k ,l). However, morphological assessment of early-born cortical neurons showed marked differences between the control and ASD groups (Fig. 5d ). Quantitative assessment of their early branching patterns showed that ASD neurons harbored aberrantly complex neurite structures at 14 days post-infection (dpi) ( Fig. 5e ,f). Together with our findings from the monolayer system and in line with the observed transcriptional dysregulation, these data highlight the existence of intrinsic ASD-associated perturbations in the sequence of cortical neuron development.
TM1-specific priming causes aberrant neurodevelopmental growth dynamics.
As the timing of neurogenesis is thought to be largely controlled by cell-intrinsic mechanisms encoded within the cortical lineage 25, 26 , we asked whether the disruption of the neotenic neurodevelopmental gene program in ASD neurons could have been primed during an earlier pre-neuronal stage in the timeline. Differential gene expression analysis indicated early aberrant gene expression dynamics in the ASD group, with an upregulation of twice as many TM1 genes within the first 4 days of differentiation ( Supplementary Table 8 ), pointing to the possible involvement of priming during preceding developmental stages. To assess the stage-specific co-expression of genes in TM1, we excluded network 
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NATure NeurOSCieNCe genes weakly interconnected with TM1 (ME-based connectivity (kME) < 0.7) and calculated the significance of gene-wise correlations to the preceding NSC stage using a signed gene significance measure ( Supplementary Fig. 7a ). As expected, a high number of TM1-specific genes featured highly significant negative correlations with the NSC stage in the control group (FDR-adjusted P < 0.05; Supplementary Fig. 7b ), indicating that these genes were downregulated in comparison to all other stages. Remarkably, almost 80% of these downregulated genes (189 of 237 negatively correlated TM1 genes) lacked significant negative gene-significance values in ASD NSCs ( Supplementary Fig. 7c and Supplementary Table 9 ). This difference between groups was also reflected in a marked shift in gene significance values for these 189 TM1 genes ( Supplementary  Fig. 7c ), suggesting a subtle primed state of the neuronal network program in ASD NSCs. Among the top negatively correlated TM1 genes, the F-box protein 2 (FBXO2) gene is involved in regulating the postmitotic neuronal state and the initiation of synapse formation 27, 28 , whereas other genes encoding for the small guanosine 5′-triphosphate-binding protein RASD2 or the transmembrane protein ISLR2 have either been implicated in schizophrenia 29 or have important functions in neurite extension and regulating forebrain connectivity 30, 31 ( Supplementary Fig. 7d -h). We tested whether an early, dynamically aberrant over-representation of TM1-related genes is sufficient to induce ASD-specific morphological and maturational changes. To assess their functional implication, we performed controlled overexpression of selected TM1 genes using FBXO2 alone as well as in combination with additional network genes ( Supplementary Fig. 7i,j) . As expected, priming the Supplementary Fig. 5a ). c, Reconstructions of retrovirus (RV)-labeled neurons derived from ASD and unaffected control individuals over time. Scale bar, 50 μ m. Experiments were performed in all 13 subject lines and two cell culture replicates per timepoint. Results are shown in d and e. d, ASD neurons showed accelerated growth properties and were significantly longer at 4, 7, and 14 dpi (two-way ANOVA with Sidak correction; 4 dpi: ***P = 0.0002; 7 dpi: **P = 0.006; 14 dpi: ****P < 0.0001). Values show means ± s.d.; ASD (n = 8; 320 technical tracing replicates in total); control (n = 5; 244 technical tracing replicates in total); n refers to biologically independent subject lines. e, Sholl analysis of neurite length from ASD and control neurons at 14 dpi. Total sholl neurite length complexity was higher in the ASD group as compared to controls (twoway ANOVA with Sidak correction, *P < 0.05, ***P < 0.001, ****P < 0.0001). Values show means ± s.e.m.; ASD (n = 8; 320 technical tracing replicates in total); control (n = 5; 244 technical tracing replicates in total); n refers to biologically independent subject lines. f, Schematic showing retroviral reporter construct designed to assess hDCX promoter activity and the flow cytometry-based gating strategy used for the assessment of hDCX:GFP mean fluorescence intensity. g, Representative histograms showing mean fluorescence intensities of the hDCX:GFP reporter through the time course of differentiation. Experiments were repeated in all 13 subject lines at five different timepoints; numerical values represent percentages. h, Relative hDCX promoter activities in differentiating neurons. ASD neurons showed premature activation of the inserted hDCX promoter, with significantly elevated levels at the NSC stage and at 16 dpi (two-way ANOVA with Sidak correction, NSC stage: **P = 0.0076; 16 dpi: **P = 0.0059). The data are normalized to the maximum activity over time within each line. Values represent means ± s.e.m.; ASD (n = 8), control (n = 5); n refers to biologically independent subject lines. See also Supplementary Fig. 5 .
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expression of FBXO2 at the NSC stage caused a dynamically aberrant initiation of the subsequent neurodevelopmental program, as measured by neurite outgrowth after 4 days of differentiation ( Supplementary Fig. 7k ,l). This effect was even more pronounced when combining FBXO2 with two additional TM1-specific network genes ( Supplementary Fig. 7l ,m), pointing to synergistic gene network-wide effects. These findings highlight the possibility that ASD-specific neurodevelopmental dysregulation is controlled by Supplementary Fig. 6k,l) . Scale bar, 20 μ m. Immunohistochemistry was repeated in six subject lines and three different organoid batches, with similar results. d, Representative confocal images of retrovirally labeled neurons in corticalplate-like regions at 14 dpi between ASD and control forebrain organoids. Scale bar, 20 μ m. Immunohistochemistry was repeated in six subject lines and three different organoid batches, with similar results. e, Developing cortical neurons of ASD subjects showed significantly accelerated growth properties at 14 dpi (*P = 0.0128, unpaired twotailed Student's t test); values represent mean ± s.e.m.; ASD: n = 3 (nine organoids with 122 tracing replicates in total); control: n = 3 (nine organoids with 142 tracing replicates in total); n refers to biologically independent subject lines. f, Sholl analysis of subtle branching patterns at 14 dpi between ASD and control cortical neurons. Sholl neurite length complexity (left) and intersections (right) were larger in the ASD group as compared to controls (two-way ANOVA with Sidak correction, *P < 0.05, **P < 0.001, ***P < 0.001). Values represent mean ± s.e.m.; ASD: n = 3 (12 organoids with 122 tracing replicates in total); control: n = 3 (12 organoids with 142 tracing replicates total); n refers to biologically independent subject lines.
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NATure NeurOSCieNCe genes identified in TM1 and could arise even before the neuronal stage through an aberrant priming of network-related genes.
Circumventing the pathologically primed NSC stage restores ASD neuron development. To evaluate whether these ASDassociated changes are indeed primed during early periods of neural development, we sought to optimize a technology that could be used to force iPSCs to circumvent early NSC-like stages. We thus generated neurons directly from iPSCs by optimizing a Neurogenin2 (Ngn2)-based induced neuron protocol 32 . IPSCs were lentivirally transduced to express rtTA and a 2A peptide-linked transcript coding for Ngn2 and eGFP (N2AG), resulting in transgenic but silent and expandable N2AG iPSCs ( Fig. 6a and Supplementary Fig. 8a ). Following iPSC-iN conversion, iPSCs underwent marked morphological changes by establishing neuronal projections as early as within 4 days ( Fig. 6b and Supplementary Fig. 8b ). As seen with neurons derived from NSCs through directed differentiation, forced expression of Ngn2 also resulted in the generation of functional neurons with high correspondence to the dorsal telencephalon during human fetal cortical development ( Fig. 6c , Supplementary  Fig. 8c-i and Supplementary Table 10 ). However, stringent assessment of early trans-differentiation events revealed that iPSC-iN conversion did not require proliferation ( Fig. 6d ) and bypassed the emergence of NSC-specific signatures ( Supplementary Fig. 9a-e ), indicating that this iPSC-iN method indeed generated neurons that had never been in an NSC-like state. We reasoned that applying this technology in the context of ASD could circumvent the critical NSC-associated priming period required for establishment of the ASD signature. A series of indepth analyses focusing on maturation and structural development throughout early neuronal growth periods were performed to reevaluate the differences between control and ASD iPSC-iNs during early neuronal differentiation. Both ASD and control iPSC-iNs underwent marked morphological changes over the time course of differentiation ( Fig. 6e ). However, quantitative assessment of neuronal differentiation revealed no difference between iPSC-iNs from ASD subjects and those generated from unaffected control individuals, as measured by neuronal commitment and neurite branching patterns (Fig. 7a,b and Supplementary Fig. 9f,g) . Further, in sharp contrast to the ASD-specific differences in the growth of neuronal projections observed in NSC-derived neurons (Fig. 4) , in-depth morphometric analysis of iPSC-iNs derived from the same iPSC clones did not show this aberrant trajectory (Fig. 7c) . To compare the developmental gene network dynamics during iPSC-iN maturation to those identified in NSC-derived neurons, we performed time-series RNA-seq analysis at different stages during iPSC-iN Articles NATure NeurOSCieNCe conversion ( Supplementary Fig. 10a ). We applied WGCNA to identify modules of co-expressed genes, similar to the approach used for NSC-derived neurons (Fig. 7d, Supplementary Fig. 10b and Supplementary Table 11 ). Comparing the networks of NSC-derived neurons (Fig. 1) to those of iPSC-iNs revealed a significant conservation of TM1 ( Supplementary Fig. 10c-e ). In sharp contrast to the NSC differentiation data, DTW revealed no trajectorial difference in the progression of the TM1-equivalent gene network between control and ASD in iPSC-iNs ( Fig. 7e and Supplementary Fig. 10f,g) . Furthermore, the prominent ASD-associated transcriptional shift among the top 60 TM1 hub genes, which was prevalent in NSCderived neurons, appeared to be abolished in IPSC-iNs ( Fig. 7f ). Thus, circumventing early NSC-like stages by using the iPSC-iN technology rescued ASD-specific phenotypes and restored aberrant transcriptional signatures in ASD neurons, suggesting a pathological priming period during early neurodevelopmental periods.
Aberrant gene network dynamics at early neuronal stages are associated with changes in chromatin accessibility at preceding NSC stages. Given the contribution of early NSC stages in the subsequent ASD-associated phenotype, we sought to further characterize possible mechanisms underlying this pathologically primed state. We reasoned that the assay for transposase-accessible chromatin using sequencing (ATAC-seq) in NSCs would allow us to obtain a depiction of preceding changes in the chromatin landscape. We thus isolated NSCs by FACS using the same surface markers as described above before subjecting them to ATAC-seq. All size-selected ATACseq libraries showed the characteristic fragment length distribution ( Supplementary Fig. 11a) , with the majority of reads falling within the nucleosome-free region ( Supplementary Fig. 11b ). We assessed differential accessibility between the two conditions and discovered 833 peaks with greater accessibility in ASD NSCs and 760 peaks with decreased accessibility in the ASD group as compared to control NSCs (Fig. 8a,b , FDR-adjusted P < 0.05). Hierarchical clustering based on the correlation of accessibility of differential accessibility sites separated the samples into two groups based on their condition ( Fig. 8c) . Similarly, the identified differential accessibility peaks could be used to separate the sample groups along the first and second principal components of variation, explaining 75 and 16% of variation, respectively ( Supplementary Fig. 11d ). 
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Differential accessibility peaks are significantly enriched in previously annotated chromatin states 33 , including promoters and enhancers, but depleted in regions containing quiescent and actively transcribed regions of the genome (Fig. 8d ). Previous studies have shown that regulatory modules as far as 50 kb and more from the transcriptional start site have important contributions to the prediction of a gene's transcriptional activity 34, 35 . Examining 50 kb windows around genes assigned to any of the three TMs showed that differential accessibility peaks with increased accessibility in ASD NSCs fall significantly more often in TM1 gene-distal regions than would be expected by chance, whereas gene-distal regions of TM2 and TM3 did not show any enrichment for differential accessibility peaks ( Fig. 8e and Supplementary Fig. 11e,f) . Remarkably, metagene analysis of gene promoters from TM1 hub genes (kME > 0.8) showed a significantly increased amount of nucleosomal depletion in ASD NSCs compared to control NSCs (273 elements, P < 6.717 × 10 −4 ); this depletion was not present in accessible promoters of randomly selected background genes ( Fig. 8f and Supplementary Fig. 11g ). These findings highlight the involvement of altered epigenetic chromatin remodeling processes and suggest that, at least in part, increased accessibility in promoter and gene-distal regions may contribute to the aberrant enhancement of transcription that occurs at the subsequent neuronal stage. In line with the finding that the manifestation of the aberrant TM1-specific signature establishes itself during early NSC-like stages, these data provide further evidence for the existence of early pathologically primed states that may trigger subsequent aberrations during ASD development.
Discussion
Our work demonstrates how ASD-associated neurodevelopmental aberrations that disturb the maturational sequence of cortical neuron development are triggered by a pathological priming of gene regulatory networks that evolve during early neural development. These findings contribute to the emerging picture of convergent molecular pathologies in ASD 3, 4, 20 and identify NSC stages as critical developmental periods that lay the groundwork for disease propensity.
Despite etiological heterogeneity, recent large-scale gene expression studies on ASD postmortem brain regions have shown consistent transcriptome changes that evolve during the first decade of brain development 20, 21, 36, 37 . These ASD-associated changes are thought to represent the consequences of an ongoing process that is triggered largely by genetic and epigenetic factors early in development 1, 21, 22, 38, 39 . However, little is known about whether this plethora of heritable genetic components might converge on a coherent gene network during specific periods of fetal cortical development. Our current study is based on a carefully selected cohort of macrocephalic ASD subjects representing a highly replicated and significant phenotype within the spectrum 8, 40, 41 . Previous ASD postmortem studies have pointed to pathologies in neuronal and micro-columnar organization, spine growth and dendrite morphology 6,42-47 , suggesting aberrant processes during early brain development. Considering that live neurons from subjects are inaccessible and most postmortem tissues are limited to later stages of disease pathogenesis, iPSC-based model systems provide an unprecedented tool to study the progression of early developmental events. Here, we have developed a time series approach that allowed us to follow human idiopathic ASD individual-specific iPSCs during their early cortico-neuronal development. Transcriptome-wide screening revealed an ASD-associated temporal dysregulation within a specific neurodevelopmental gene module that caused marked changes in the maturational sequence of cortical neuron development, including morphological growth acceleration and heterochronic initiation of the neuronal program. It is likely that a disruption of the neotenic gene expression program during cortical neuron development has wide-ranging consequences for a timely, coordinated establishment of interconnected neuronal networks. Experiments in rodents have shown that altering the trajectory of early postnatal cortical development can lead to structural and behavioral features of autism 48, 49 . In line with this finding, human iPSC-based studies have confirmed that neuronal connectivity is affected in various forms of autism [9] [10] [11] . However, while cortical neurons are thought to be particularly susceptible for certain ASD risk genes 3, 4 , it is currently not well understood whether common ASD-associated changes that evolve at the neuronal stage are the consequence of an ongoing process that is primed early in development.
Here we show that the observed neurodevelopmental heterochronicity in ASD neurons originates from functional neurodevelopmental gene networks that become pathologically primed during the pre-neuronal NSC stage. By mimicking this ASD-specific signature in control NSCs using controlled over-representation of a subset of network genes, we show that pathological dysregulation in NSCs is sufficient to induce ASD-associated morphological and maturational changes at later neuronal stages. While we tested only a selected subset of network-related genes, it would be interesting to investigate how different combinations of network genes may contribute to ASD-associated changes in a context-and subject-specific manner.
Trans-differentiation of somatic cells such as fibroblasts into induced neurons has been used as an alternative technology to directed differentiation 50 . More recently this technology has been expanded to enable rapid generation of functional neurons by transgenic overexpression of proneural transcription factors in iPSCs 32 . However, it is well established that forced expression of induced neuron pioneer factors during fibroblast-based induced neuron conversion does not require proliferation 51 . A recent study furthermore demonstrated that the direct programming path diverges into a novel transitional state, bypassing intermediate progenitors but converging onto the same final state 52 . In line with our findings, these data indicate that iPSC-iNs indeed generate neurons that have never been in a NSC-like state, thus making them a promising tool to evaluate the implication of early neurodevelopmental states in priming disease progression. Using this technology, we demonstrate that bypassing NSC-like stages by direct conversion of ASD iPSCs into postmitotic neurons prevents manifestation of the observed neuronal ASD-associated phenotypes. Our analysis suggests that some ASD-associated changes are likely to be the consequence of pathological events that are triggered during NSC stages early in development. A genome-wide analysis of the chromatin state further identified a contribution of preceding epigenetic changes to priming disease propensity. Future studies are needed to assess the implication of specific epigenetic aspects on the onset and severity of autism-related disease trajectories. Finally, given the growing evidence of specific neurodevelopmental alterations in ASD, these findings and the methodological framework will be valuable for guiding future mechanistic studies aimed at identifying a convergence of causal genetic variations that contribute to ASD risk.
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Neural differentiation. We differentiated iPSCs into NSCs by following a default differentiation protocol as previously described 9, 55 . Briefly, iPSC colonies were detached by collagenase (Gibco) to form embryoid bodies and then cultured in suspension in the presence of 1 μ M dorsomorphin (Cayman Chemical). After floating for 7 days, embryoid bodies were attached on poly-ornithine (10 μ g ml -1 , Life Technologies)-and laminin (5 μ g ml -1 , Life Technologies)-coated surfaces. At day 16, emerging rosette colonies were manually detached, gently dissociated with accutase (Innovative Cell Technologies) and plated as NSC monolayers onto coated dishes for further neuronal differentiation.
Retroviral lineage tracing and neuronal differentiation.
Replication-incompetent retrovirus was produced as described in Supplementary Methods. For retroviral lineage-tracing experiments, human NSCs were plated at a density of 5 × 10 4 cells per cm 2 onto coverslips or dishes coated with poly-ornithine (10 μ g ml -1 , Life Technologies) and laminin (5 μ g ml -1 , Life Technologies). The next day, the medium was changed to neuron differentiation medium and sparse labeling of NSCs was achieved using short-time pulse infections with low-titer retroviral particles (for constructs, see Supplementary Methods). This medium is based on DMEM:F12/Neurobasal (both Gibco) (1:1) and contains the following supplements: N2 supplement (1× , Gibco), B27 supplement (1× , Gibco) and laminin (1 μ g ml -1 , Life Technologies). After 6 h, the remaining viral particles were washed out and the medium was replaced with neuronal differential medium. For subsequent analyses, maturing neuronal cultures were followed for 2, 4, 7 and 14 dpi in vitro before being processed for immunocytochemistry, electrophysiology, flow cytometry or FACS-based purification.
Direct conversion of human iPSCs into iPSC-iN.
We transduced iPSCs with lentiviral particles for pLV-X-UbC:TetOn and pLV-X-Ngn2:2 A:eGFP, and these were selected in the presence of puromycin (0.5 μ g ml -1 , Sigma Aldrich) and G418 (100 μ g ml -1 , Life technologies). For iPSC-iN conversion, iPSCs were transferred to PluriPro monolayer conditions (Cell Guidance Systems) and, 24 h after plating, were induced with doxycycline (2 μ g ml -1 , Sigma Aldrich) for 2 days. For further maturation, induced neurons were switched to neuron maturation medium (see above for details) based on DMEM:F12/Neurobasal (both Gibco) (1:1) as used for directed differentiation. This medium contains the following supplements: N2 supplement (1× , Gibco), B27 supplement (1× , Gibco), laminin (1 μ g ml -1 , Life Technologies) and doxycycline (2 μ g ml -1 , Sigma Aldrich). The medium was changed every other day. For electrophysiological recordings, induced neurons were dislodged 4 days after conversion using TrypLE (Gibco), sorted based on eGFP expression and re-plated onto coverslips coated with poly-ornithine (10 μ g ml -1 , Life Technologies) and laminin (5 μ g ml -1 , Life Technologies).
FACS-based purification and RNA isolation.
Neural stem cells and maturing neuron cultures, as well as iPSCs and iPSC-iNs, were detached using accutase (Innovative Cell Technologies) and then washed and stained with fluorophorecoupled antibodies (see Supplementary Methods) for 45 min at 4 °C in phosphatebuffered saline (PBS). Cells were washed, suspended in PBS and filtered using a 40 μ m cell strainer. The desired cell populations were sorted directly into Trizol-LS (Life Technologies). RNA was isolated according to the manufacturer's instructions and subsequently digested with TURBO DNase to remove trace quantities of DNA (ambion, Life Technologies). Before RNA-seq library preparation, assessment of RNA integrity numbers was performed using Agilent TapeStation.
RNA-seq and data preprocessing. Libraries were prepared using the TruSeq Stranded mRNA Sample Prep Kit according to the manufacturer's instructions (Illumina). We performed 50 base pair (bp) single-end sequencing using the Illumina HiSeq 2500 platform. Adapter trimming and low-quality ends removal were conducted using Trimmomatic 56 , and trimmed reads were mapped to hg38 using STAR 57 . Expression values, heatmaps and clustering were performed using R 3.3.0 and RStudio 0.99.489 software based on variance-stabilizing transformation, and differential gene expression was calculated using the DESeq2 package 58 .
WGCNA.
A signed co-expression network was built using the WGCNA 1.51 package in R. All 65 time series samples were included in the network (five controls and eight ASDs at five time points), and 52 time series samples for the iPSC-iN timeline (five controls and eight ASDs at four time points). Network construction was performed by first creating a matrix of pairwise correlations between all pairs of genes across the measured samples. The adjacency matrix was then constructed by raising the co-expression measure (0.5 + 0.5 × correlation matrix) to the power of β = 12 (or β = 14 for the iPSC-iNs time series), which is interpreted as a soft threshold of the correlation matrix 15 . Based on the resulting adjacency matrix, we next calculated the topological overlap as a robust and biologically meaningful measure of network interconnectedness 59 . Average linkage hierarchical clustering was performed to group genes with highly similar co-expression relationships. Using the dynamic hybrid tree cut algorithm 60 , we defined modules as branches resulting from the tree cutting of the hierarchical clustering tree. To obtain moderately large and distinct modules, we set the minimal module size to 30 genes and merged modules whose eigengenes were highly correlated (correlation > 0.6). The expression profiles for each module were summarized by representing them as the first principal component (module eigengene), thus explaining the maximum amount of variation in the module expression levels. Module membership measures were defined for each module as the correlation between gene expression values and the module eigengene (kME). To identify modules that gradually changed over time, a time-based significance measure was defined as the absolute correlation between time (dpi or days of in vitro differentiation post-lineage tracing) and the gene expression profiles across all 65 samples. This measure was used to compute the module significances as the average gene significance measure for all genes in a given module (Fig. 1d ).
DTW.
Expression dynamics of time-related modules were compared using a DTW-based approach 61, 62 to calculate the distance between ASD and control time series gene expression data. In brief, we used the expression profiles of the ME calculated by WGCNA and applied smoothing to enhance time resolution. The DTW package 62 was then used to create a distance measure by locally compressing or stretching (warping) the query ME profile to best match the reference ME profile. The more warping that is required, the greater the difference between the two timelines. Calculation of the global alignment path used the full data window, symmetric continuity constraint and Euclidean distance to measure path differences 62 . The plots were generated by summing the distances of individual aligned elements.
Gene significance measures and network visualization. Gene significance measures were used to incorporate external information into the co-expression network. These measures were defined as correlations between gene expression values and trait-specific cellular stage (time point). The advantages of using correlations to quantify trait relationships are that this measure can take on either positive or negative values (− 1, 1), and that a P value is readily computed. Thus, gene significance indicates whether the gene has a positive or negative relationship with the trait-specific time point. In combination with kME, gene significicance was used to assess stage-specific expression or suppression of intramodular genes. Central hub genes of TM1 (genes with the highest kME) were depicted using Cystoscape (version 3.3.0) 63 . In these plots, each point is a gene (or node) and gene-gene connections (or edges) are shown as light yellow or light red lines. Edge width values (gene-gene connection weight) are displayed with increasing thickness. The positioning of the nodes is done by first using an automatic layout and then by manually adjusting the positions so that gene names are visible. In the plot showing the hub genes of TM1, ASD risk genes are displayed in red and selected term memberships as a colored bar graph next to the node. Different point sizes correspond to the number of time points showing increased expression (> 0.25 log 2 (fold change)) for the genes displayed. Significantly suppressed hub genes at the NSC stage are depicted in a second plot. Here, a gradually increasing point size of nodes corresponds to gene-significance values at the control NSC stage.
Gene ontology analysis. Functional annotation was performed with the Database for Annotation, Visualization and Integrated Discovery Bioinformatics resource 64 and The Gene Ontology Consortium 65 . For differentially expressed genes and co-expression modules, the background was set to the total list of genes expressed in our dataset. In Database for Annotation, Visualization and Integrated Discovery Bioinformatics-based analysis, the reported P values are derived from the expression analysis systematic explorer score probability, a modified Fisher's exact test that is more stringent than the standard Fisher's exact test in examining gene lists 66 . Where indicated, significance of over-representation was adjusted to control the false discovery rate by means of the Benjamini-Hochberg procedure. The statistical significance threshold for all gene ontology analyses was P < 0.01.
Immunocytochemistry. Cells were washed in PBS, fixed with 4% paraformaldehyde for 20 min at room temperature and blocked with 5% horse serum in PBS containing 0.1% TritonX-100. Primary antibodies were incubated overnight at 4 °C, washed three times with PBS, incubated with secondary antibodies for 2 h at room temperature, stained with DAPI solution and mounted in PVA-DABCO mounting solution (Sigma Aldrich). For confocal imaging, cells were grown on ibidi μ -slides. Antibodies and respective concentrations are listed in Supplementary Methods.
Imaging. Image data were captured and processed using both a confocal microscope system (Zeiss LSM780) and a Zeiss CSU Spinning Disk Confocal Microscope, equipped with a Yokogawa spinning disc scan head with an EM-CCD camera. Flow cytometry analysis was performed with a BD LSR II (Becton-Dickinson), and the BD InFlux Cytometer (Becton-Dickinson) was used for FACSbased purification of neuronal cell types.
Morphometric analyses.
Tiled image stacks were processed using ZEN Imaging software (Carl Zeiss Microscopy) and exported as TIFF files. Neurolucida version 11 (MBF Bioscience) was used to reconstruct individual retrovirus-labeled neurons over time. In total, 10-20 traces per line (eight ASD and five control lines with one or two clones per line, n total = 564 cells) were analyzed at three different time points (4, 7 and 14 dpi) and plotted as mean for every individual. Identification of individual neurons was based on co-expression of the markers PSA-NCAM and DCX. Reconstructions were based on the extent of membrane-bound GFP expression labeled through RV-CAG:LckN-eGFP. IPSC-iNs were traced at the time points indicated post-induction (4, 7 and 14 days post-doxycycline). In total, 10-30 traces per line (eight ASD and five control lines with one or two clones per line, n total = 746 cells; Supplementary Table 7 ) were analyzed and plotted as mean for every individual. For Sholl analysis, 5 or 10 μ m increments were used to define the gradually increasing radius of concentric circles centered at the centroid of the cell soma. Subsequent analysis of global and subtle branching patterns was performed using Neurolucida Explorer (MBF Bioscience) and Microsoft Excel.
Generation of cerebral organoids. Cerebral organoids were generated and processed for analysis as described previously 23 with minor modifications. Briefly, iPSCs were washed with Dulbecco's phosphate-buffered saline (Invitrogen) and dissociated with EDTA followed by Accutase to generate single cells. A total of 1 × 10 4 cells were then seeded into each well of an ultra-low-attachment 96-well plate (Nunc) to form single embryoid bodies in medium containing DMEM/F12, 20% KOSR, 3% fetal bovine serum, 2 mM GlutaMAX, 1% non-essential amino acids, 50 nM b-mercaptoethanol and 4 ng ml -1 bFGF. ROCK inhibitor Y27632 (40 uM) was included for the first 24 h. After 2 days, the medium was changed (same medium but without FGF) and embryoid bodies were grown for another 3-4 days. Medium was then changed to neural induction medium, consisting of DMEM/F12, 1× N2 supplement, 1% non-essential amino acids, 2 mM GlutaMAX and 1 ug ml -1 heparin (Sigma). On days 10-12, embryoid bodies were embedded in 30 ul droplets of Matrigel and allowed to gel at 37 °C for 20-30 min. Embedded embryoid bodies were subsequently cultured in cerebral differentiation medium comprising 50% DMEM/F12, 50% Neurobasal, 0.5× N2 supplement, 1× B27 (without RA) supplement, 2 mM GlutaMAX, 2.8 ng ml -1 human insulin (Sigma), 0.5% non-essential amino acids and 55 µ M b-mercaptoethanol. Droplets were cultured in stationary condition in 6 cm suspension culture dishes (Corning) for 4 days, transferred to an orbital shaker (65-80 rpm) and cultured in cerebral differentiation medium + RA media for up to five weeks.
Generation of forebrain organoids and retroviral labeling. Forebrain organoids were generated as described previously 24 with minor modifications. Human iPSC colonies were detached before reaching confluency with collagenase Type IV (Gibco) and transferred to an Ultra-Low attachment 10 cm plate (Corning Costar), containing 10 ml hPSC medium, consisting of DMEM:F12 (Invitrogen), 20% Knockout Serum Replacer (Gibco), 1× Non-essential Amino Acids (Invitrogen), 1× 2-mercaptoethanol (Gibco), 1× GlutaMAX (Invitrogen), 10 ng ml -1 FGF-2 (Peprotech) and ROCK inhibitor Y27632 (10 μ M). Twenty-four hours later, the medium was replaced with induction medium containing hPSC media without FGF-2, 2 μ M dorsomorphin (Cayman Chemical) and 2μ M A-083 (Stemgent). At day 5 the media were replaced with neural induction medium consisting of DMEM:F12 (Invitrogen), 1× N2 Supplement (Invitrogen), 1× Non-essential Amino Acids (Invitrogen), 1× GlutaMAX (Invitrogen), 10 μ g ml -1 Heparin (Sigma), 1× Penicillin/Streptomycin (Gibco), 10 μ M CHIR99021 (Cayman) and 1 μ M SB-431542 (Stemgent). Seven days after induction, organoids were embedded in 20 μ l Matrigel (Trevigen) droplets and continued to grow for an additional week in 6 cm Ultra-Low attachment plates (Corning Costar). From day 14 onwards, organoids were cultured in differentiation medium comprising DMEM:F12 (Invitrogen), 1× N2 and B27 Supplements (Invitrogen), 1× Non-essential Amino Acids (Invitrogen), 1× GlutaMAX (Invitrogen), 1× 2-Mercaptoethanol (Gibco), 1× Penicillin/Streptomycin (Gibco) and 2.5 μ g ml -1 Insulin (Sigma), and transferred to an orbital shaker (65-80 rpm) . At day 20, residual Matrigel was removed and media changes were performed every 2-3 days using the aforementioned differentiation medium. Labeling with RV-CAG:LckN-eGFP was performed in 4-week-old forebrain organoids using a titer range of approximately 10 5 -10 6 colony-forming units ml -1 . After 12 h of incubation, organoids were washed and cultured for up to 10 weeks.
Forebrain organoids were stained with TBR1 at 6 weeks to define CP-like regions and to measure the thickness of the evolving plate. Four independent measurements per ventricular structure of sub-segmented fields (specified in Supplementary Fig. 6g) were averaged, and a total of three forebrain organoids with two to three 'VZ-like' regions per organoid were quantified for every subject line using three ASD and three control individuals (n total = 17 organoids; see Supplementary Table 7 for details). Retrovirally labeled newborn neurons were analyzed in forebrain organoids at 14 dpi in regions that showed clearly defined VZ-like and CP-like structures. Three-dimensional reconstructions were based on the extent of membrane-bound GFP (RV-CAG:LckN-eGFP) in newborn neurons located within cortical plate-like regions and analyzed with the software detailed above (morphometric analysis). In total, 30-60 traces per line (three ASD and three control lines with three organoid replicates per individual, n total = 264 cells; Supplementary Table 7 ) were analyzed and plotted as mean for every individual.
Assay for ATAC-seq. A total of 70,000 FACS-purified NSCs were lysed in 50 μ l lysis buffer (10 mM Tris-HCl ph 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.1% IGEPAL, CA-630, in water) on ice and nuclei were pelleted by centrifugation at 500g for 10 min. Nuclei were then resuspended in 50 µ l transposase reaction mix (1× Tagment DNA buffer (Illumina 15027866), 2.5 µ l Tagment DNA enzyme I (Illumina 15027865), in water) and incubated at 37 °C for 30 min. DNA was then purified with Zymo ChIP DNA concentrator columns (Zymo Research D5205) and eluted with 10 µ l of elution buffer. DNA was then amplified with PCR mix (1.25 µ M Nextera primer 1, 1.25 µ M Nextera index primer 2-bar code, 0.6× SYBR Green I (Life Technologies, S7563), 1× NEBNext High-Fidelity and 2× PCR MasterMix (NEBM0541)) for 8-12 cycles, size selected for fragments (160-500 bp) by gel extraction (10% TBE gels, Life Technologies EC62752BOX) and 125 bp paired-end sequenced on an Illumina HiSeq 2500 platform.
ATAC-seq pre-processing and peak calling. FASTQ sequencing files from ATACseq experiments were mapped to the University of California, Santa Cruz genome (hg38) using Bowtie2 with default parameters 67 . For all data files, optical and PCR duplicates were removed using PicardTools. De-duplicated BAM files from the same sample were merged and PicardTools was again used to remove duplicate reads. Only uniquely mapped and properly paired reads were kept and those reads falling into the mitochondrial genome, unmapped contigs and blacklisted regions (http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/hg38-human/) were removed, resulting in more than 55 M high-quality reads on average. All samples showed the characteristic fragment length distribution, with more than 70% of reads falling within the nucleosome-free region and a mono-nucleosomal peak representing reads that cut on both sides of a nucleosome (~180-247 bp in length). For peak calling of open chromatin, reads were filtered using the deeptools2 68 command 'alignmentSieve.py' with the following parameters: '--ATACshift --minMappingQuality 30 --maxFragmentLength 100' , obtaining only properly paired reads within nucleosome-free regions (< 100 bp). MACS2 (version 2.1.1.20160309) was then used to call peaks on filtered BAM files using the following command:
'macs2 callpeak -g hs -q 0.05 --nomodel --keep-dup all --broad -f BAMPE' ATAC-seq data analysis. For differential accessibility analysis, we used DiffBind v2.4.8 69 to first perform a weighted overlap analysis (dba.count). The number of reads within each peak of the union peakset was counted and normalized for sequencing depth using the total number of non-mitochondrial reads present in the peaks for each sample. The edgeR v3.18.1 package was then used to contrast the control and ASD group using the DiffBind function 'dba.analyze' with the settings for edgeR (method = DBA_EDGER). The differential accessibility heatmap (Fig. 8b ) displays the normalized peak accessibility scores for each sample. These scores were calculated using the DiffBind default setting 'DBA_SCORE_TMM_ READS_FULL' , which uses the trimmed mean of M values normalization built into the edgeR package using read counts and full library size. Coverage plots ( Fig. 8a and Supplementary Fig. 11f ) display normalized read counts-the number of reads within a peak divided by the sequencing depth-and were generated with Gviz 70 using hg38 NCBI RefSeq gene model annotations downloaded from the University of California, Santa Cruz genome browser.
To generate metagene profiles of promoter regions, HOMER was first used to convert aligned and filtered reads into 'tag directories' for further analysis 71 
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